BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 3, 2005
View Archived Issues
Questioning creates knowledge: the Summer/Fall 2005 issue of Prous Science News now available
Read More
BioInvent set to begin U.K. study of BI-201 for HIV
Read More
Antisense Therapeutics updates development status
Read More
Astex receives CTA approval for AT-7519 and selects new drug candidates
Read More
Bionomics to acquire Iliad Chemicals
Read More
Treatment begins in phase IIb colorectal cancer study of CoFactor
Read More
Centocor extends enrollment for phase II Crohn's disease study of CNTO-1275
Read More
Enrollment progresses well in phase III FavId study in NHL
Read More
Approvable letter for nebivolol
Read More
Arena tests a new 5-HT2C receptor agonist for obesity treatment
Read More
Novel chemokine CXCR2 antagonist effective against lung neutrophilia in mice
Read More
Better effects of DPI-221 than morphine or oxybutynin on micturition in rats
Read More
VT-111/ciclosporin combination therapy prevents cardiac transplant rejection
Read More
Mechanisms underlying of PG-490-88/FK-506 renal allograft survival
Read More
A selective ETA antagonist prevents pancreatic I/R injury
Read More
Therapeutic potential for JNJ-7777120 in allergic airway disease
Read More
Preclinical studies demonstrate that R-406 may be a potential asthma therapy
Read More
ONO-6126: a treatment for COPD
Read More
Prous Science webcasts James D. Watson conference
Read More
ACR-16 recommended for orphan drug status for Huntington's disease
Read More
COMP recommends orphan drug status for 1D09C3 for Hodgkin's lymphoma
Read More
Inspire submits NDA amendment for diquafosol for dry eye
Read More
Not approvable letter for Risperdal for psychosis of Alzheimer's disease
Read More
Allergan receives written FDA response for oral tazarotene NDA
Read More
Novel treatments for respiratory and allergic disorders disclosed in recent patents
Read More
Canadian approval of Glumetza for type 2 diabetes
Read More
Daiichi and Sankyo sign definitive agreement on business integration
Read More
Novel antiinflammatory agents imparted in recent patent literature
Read More
A curcumin/quercetin combination improves early kidney graft function
Read More